A Study of Three-dimensional (3-D) Tissue Models in Patients with Serous Endometrial Cancer Planning to Undergo Surgery

Overview

About this study

The purpose of this research study is to learn more about serous endometrial cancer by creating three-dimensional (3-D) tissue models in the laboratory setting.  The tissue models will provide scientists with a reliable, sensitive method to test biomarkers and cellular responses to treatment for endometrial cancer.   

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Preoperative diagnosis (D&C) of serous endometrial cancer
  • Age > 18
  • Able to give informed consent

Exclusion Criteria: 

  • Patients submitted to neoadjuvant chemotherapy
  • Previous radiation therapy
  • Synchronous cancer

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Andrea Mariani, M.D., M.S.

Closed for enrollment

Jacksonville, Fla.

Mayo Clinic principal investigator

Andrea Mariani, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Panagiotis Anastasiadis Ph.D.

(904)953-6005

Anastasiadis.Panos@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20359615

Mayo Clinic Footer